Vellus-to-terminal Hair Follicle Reconversion Occurs in Male Pattern Balding and is Promoted by Minoxidil and Platelet-rich Plasma: In Vivo Evidence from a New Humanized Mouse Model of Androgenetic Alopecia
DOI:
https://doi.org/10.2340/actadv.v103.12320Keywords:
androgenetic alopecia, Vellus-to-terminal, minoxidil, PRP, humanized mouse modelAbstract
Abstract is missing (Short communication)
Downloads
References
Rushton DH, Westgate GE, Van Neste DJ. Following historical "tracks" of hair follicle miniaturisation in patterned hair loss: are elastin bodies the forgotten aetiology? Exp Dermatol 2022; 31: 102-109.
https://doi.org/10.1111/exd.14393 DOI: https://doi.org/10.1111/exd.14393
Guarrera M, Rebora A. The higher number and longer duration of kenogen hairs are the main cause of the hair rarefaction in androgenetic alopecia. Skin Appendage Disord 2019; 5: 152-154.
https://doi.org/10.1159/000493587 DOI: https://doi.org/10.1159/000493587
Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc 1999; 4: 282-284.
https://doi.org/10.1038/sj.jidsp.5640230 DOI: https://doi.org/10.1038/sj.jidsp.5640230
Miranda BH, Charlesworth MR, Tobin DJ, Sharpe DT, Randall VA. Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life. FASEB J 2018; 32: 795-806.
https://doi.org/10.1096/fj.201700260RR DOI: https://doi.org/10.1096/fj.201700260RR
Tsuboi R, Niiyama S, Irisawa R, Harada K, Nakazawa Y, Kishimoto J. Autologous cell-based therapy for male and female pattern hair loss using dermal sheath cup cells: a randomized placebo-controlled double-blinded dose-finding clinical study. J Am Acad Dermatol 2020; 83: 109-116.
https://doi.org/10.1016/j.jaad.2020.02.033 DOI: https://doi.org/10.1016/j.jaad.2020.02.033
Hawkshaw NJ, Paus R. Beyond the NFAT horizon: from cyclosporine A-induced adverse skin effects to novel therapeutics. Trends Pharmacol Sci 2021; 42: 316-328.
https://doi.org/10.1016/j.tips.2021.02.001 DOI: https://doi.org/10.1016/j.tips.2021.02.001
Sinclair R. Androgenetic alopecia. Modelling progression and regrowth. Exp Dermatol 2016; 25: 424-425.
https://doi.org/10.1111/exd.13029 DOI: https://doi.org/10.1111/exd.13029
Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M, et al.; European Consensus Group. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 2011; 164: 5-15.
https://doi.org/10.1111/j.1365-2133.2010.10011.x DOI: https://doi.org/10.1111/j.1365-2133.2010.10011.x
Oh JW, Kloepper J, Langan EA, Kim Y, Yeo J, Kim MJ, et al. A guide to studying human hair follicle cycling in vivo. J Invest Dermatol 2016; 136: 34-44.
https://doi.org/10.1038/JID.2015.354 DOI: https://doi.org/10.1038/JID.2015.354
Laufer Britva R, Keren A, Ginzburg A, Ullmann Y, Paus R, Gilhar A. Evidence from a humanized mouse model of androgenetic alopecia that platelet-rich plasma stimulates hair regrowth, hair shaft diameter and vellus-to-terminal hair reconversion in vivo. Br J Dermatol 2021; 185: 644-646.
https://doi.org/10.1111/bjd.20084 DOI: https://doi.org/10.1111/bjd.20084
Gilhar A, Keren A, Ullmann Y, Wu J, Paus R. Effect of minoxidil formulations on human scalp skin xenotransplants on SCID mice: a novel pre-clinical in vivo assay for androgenetic alopecia research. Exp Dermatol 2022; 31: 980-982.
https://doi.org/10.1111/exd.14523 DOI: https://doi.org/10.1111/exd.14523
Blume U, Ferracin J, Verschoore M, Czernielewski JM, Schaefer H. Physiology of the vellus hair follicle: hair growth and sebum excretion. Br J Dermatol 1991; 124: 21-28.
https://doi.org/10.1111/j.1365-2133.1991.tb03277.x DOI: https://doi.org/10.1111/j.1365-2133.1991.tb03277.x
Piccini I, Sousa M, Altendorf S, Jimenez F, Rossi A, Funk W, et al. Intermediate hair follicles from patients with female pattern hair loss are associated with nutrient insufficiency and a quiescent metabolic phenotype. Nutrients 2022; 14: 3357.
https://doi.org/10.3390/nu14163357 DOI: https://doi.org/10.3390/nu14163357
Yazdabadi A, Whiting D, Rufaut N, Sinclair R. Miniaturized hairs maintain contact with the arrector pili muscle in alopecia areata but not in androgenetic alopecia: a model for reversible miniaturization and potential for hair regrowth. Int J Trichology 2012; 4: 154-157.
https://doi.org/10.4103/0974-7753.100069 DOI: https://doi.org/10.4103/0974-7753.100069
Eichmüller S, van der Veen C, Moll I, Hermes B, Hofmann U, Müller-Röver S, et al. Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem 1998; 46: 361-370.
https://doi.org/10.1177/002215549804600310 DOI: https://doi.org/10.1177/002215549804600310
Fu D, Huang J, Li K, Chen Y, He Y, Sun Y, et al. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia. Biomed Pharmacother 2021; 137: 111247.
https://doi.org/10.1016/j.biopha.2021.111247 DOI: https://doi.org/10.1016/j.biopha.2021.111247
Downloads
Published
How to Cite
License
Copyright (c) 2023 Amos Gilhar, Aviad Keren, Ralf Paus
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.